Close
Help




JOURNAL

Clinical Medicine Reviews in Therapeutics

A Review of Pregabalin for the Treatment of Peripheral and Central Neuropathic Pain and Its Place in the Treatment of Chronic Pain

Submit a Paper


Clinical Medicine Reviews in Therapeutics 2011:3 325-346

Review

Published on 19 Sep 2011

DOI: 10.4137/CMRT.S7398


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Therapeutics

Abstract

Pregabalin is an alpha2-gamma ligand indicated for the treatment of peripheral and central neuropathic pain. In this article, we will review the pharmacodynamics, pharmacokinetics, randomized clinical trials supporting its efficacy for a wide array of neuropathic painful conditions, and the tolerability of this medication. We will comment the main differences with gabapentin, its parent compound, both from the pharmacological and clinical perspective. Our experience in the clinical practice setting with pregabalin, its use in patients with refractory neuropathic pain and its rational use in combination regimens will also be reviewed. With all this information in mind, the place of pregabalin in the pharmacotherapy of neuropathic pain is explored, mainly through the review of recent clinical guidelines which, in fact, place pregabalin among the first-line treatments for the management of most neuropathic painful conditions.



Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)




What Your Colleagues Say About Libertas Academica
It was a nice experience for me to publish my first paper in Evolutionary Bioinformatics.  The peer review process was fast, critical, helpful and fair. The production process was also fast and accurate. Thanks for your hard work.
Dr Kangquan Yin (Peking University, Beijing, PRC)
More Testimonials

Quick Links


New article and journal news notification services